Originally published In Press as doi:10.1074/jbc.M111503200 on March 12, 2002
J. Biol. Chem., Vol. 277, Issue 21, 18494-18500, May 24, 2002
Elovl1 and p55Cdc Genes Are Localized in
a Tail-to-Tail Array and Are Co-expressed in Proliferating Cells*
Abolfazl
Asadi,
Johanna
Jörgensen, and
Anders
Jacobsson
From the Wenner-Gren Institute, The Arrhenius Laboratories F3,
Stockholm University, SE-106 91 Stockholm, Sweden
Received for publication, December 3, 2001, and in revised form, February 25, 2002
 |
ABSTRACT |
Elovl1 is a ubiquitously expressed
gene, the product of which belongs to a highly conserved family of
microsomal enzymes, which are involved in the formation of very long
chain fatty acids and sphingolipids in yeast to man. To elucidate the
structure and regulation of the Elovl gene we have isolated
a lambda phage genomic DNA clone containing the entire mouse gene and
found that Elovl1 consists of eight exons that are
dispersed over 5.4 kb of genomic sequence. Interestingly,
sequencing of the lambda clone to completion revealed that the insert
contained a segment of the cell cycle gene p55Cdc directed
in the opposite orientation. The genes are very tightly linked so that
the 3'-end of the long mRNA species are complementary over a
short stretch of nucleotides. Although both Elovl1 and
p55Cdc are highly conserved genes, a BLAST search implies
that the tail-to-tail arrangement has evolved in vertebrates. Despite
the non-similar expression pattern in different tissues, mRNA
analysis of the two genes disclosed simultaneous transcription during a
proliferation-differentiation transition state, which suggests that the
two genes may be regulated through a common bi-directional
transcription mechanism under specific conditions.
 |
INTRODUCTION |
Very long chain fatty acids
(VLCFA)1 have been recognized
as structural components in a variety of fat molecules such as
glycerophospholipids, sphingolipids, and wax- and sterol esters.
Depending on their chain length and degree of unsaturation, they
contribute to the fluidity and other physical and chemical properties
of the membrane. VLCFA are found in virtually all cells and are major
constituents of the brain, skin and testis. For example, the brain
contains high amounts of VLCFA consisting of 24 or more carbons, which are required for normal brain myelination (1). VLCFA are also needed in
the synthesis of ceramides, which are necessary for the formation and
function of the permeability layer of the skin. The ceramides, together
with free VLCFA, comprise more than 50% of the fatty acids found in
the epidermis, the outermost layer of the skin, which is the highest
amount present in any mammalian tissue (2).
Synthesis of VLCFA is performed in the endoplasmic reticulum and in
mitochondria by membrane-bound enzymes; the former is more prominent
(3). Elovl12 (4)
is a highly conserved gene that shows extensive sequence identity to
the earlier identified gene Elovl3 (5, 6). Both are members
of a recently identified mammalian gene family whose products have been
shown to be involved in the formation of VLCFA and sphingolipids (4,
7-13).
Elovl1 is expressed in all tissues tested and the enzyme is
believed to elongate very long fatty acids up to C26 (4).
Especially high levels of expression are found in stomach, lung,
kidney, skin, and intestine (4), which suggests that ELOVL1 may be important for developing a proper barrier in epithelial cells and skin. In addition, ELOVL1 has also been suggested to be a crucial
enzyme involved in the formation of myelin in the central nervous
system in mouse (4).
Although the Elovl1 mRNA sequence has been
identified, very little is known about the genetic nature of mammalian
fatty acid chain elongation enzymes. To scrutinize the genomic
background and regulation of Elovl1 in greater detail we
have isolated a lambda phage genomic DNA clone containing the entire
mouse Elovl1 gene. Surprisingly, we found that the
Elovl1 gene is linked to the gene coding for the cell cycle
protein p55Cdc (14) in a bi-directional manner. Despite the
fact that both genes are very tightly linked and expressed in all cell
types at some point, our findings indicate a complex co-regulation
during the cell cycle. Even more surprising is that a similar
tail-to-tail arrangement was also found for the Elovl3 gene
and the homeobox gene Pitx3 (6). It is therefore intriguing
that two closely related genes from the same gene family are both
juxtaposed with two completely unrelated genes in a tail-to-tail arrangement.
 |
MATERIALS AND METHODS |
Mouse Elovl1 Genomic Cloning--
Genomic clones of
Elovl1 were isolated by plaque hybridization of a commercial
mouse 129 strain liver genomic DNA library in the Lambda FIX II vector
(Stratagene, cat. no. 946308) with a 32P-labeled probe
corresponding to 0.92 kb from the 5'-end of the Elovl1
cDNA (GenBankTM accession no. AF170907). Hybridization
was carried out overnight at 45 °C in 50% formamide, 5× SSC, 5×
Denhardt's solution, 50 mM sodium phosphate, pH 6.5, 0.5%
SDS, and 100 µg/ml degraded herring sperm DNA. The membranes were
first washed twice for 15 min at room temperature in 2× SSC, 0.1%
SDS, and a high stringency wash was then performed at 55 °C in 0.1×
SSC, 0.1% SDS for 15-30 min. Screening of ~1.5 × 106 plaques yielded one positive recombinant, which was
isolated by two additional rounds of plaque purification. Phage DNA was prepared on a large scale by the polyethylene glycol precipitation method according to Ref. 15. Restriction fragments generated by various
combinations of restriction enzymes were analyzed by Southern blotting.
Mouse p55Cdc cDNA Cloning--
For sequencing of a
full-length mouse p55Cdc cDNA, we combined the sequences
from three EST clones (accession nos. AI327152, AA497914, and AA537091)
obtained from the I.M.A.G.E. Consortium and a 735-bp RT-PCR
(Promega, cat. no. A1250) product obtained from mouse liver total
RNA covering the 3'-end of p55Cdc mRNA. At
least two independent PCR products were sequenced to check that no
amplification errors occurred. RT-PCR experiments were performed using
primer 5'-GATCAAGGAGGGCAACTACC-3' for the 5'-end and primer
5'-GCTTTTTCCCGCTACGCCGA-3' for the 3'-end. The PCR products were
subcloned into pCR-XL-TOPO vector (Invitrogen, cat. no. K4700-10) and sequenced.
DNA Sequencing and Sequence Analysis--
Using recombinant
phage DNA as a template, the genomic insert was sequenced by the primer
walking strategy. Sequencing was performed with an ABI 373A automatic
DNA sequencer (Applied Biosystems) on reactions prepared by the
dye-termination method, using the ABI Prisms Dye Terminator Cycle
Sequencing Ready Reaction kit (PerkinElmer Life Sciences, Applied
Biosystems, cat. no. 4303149). The sequence information was compiled
and analyzed with the use of the University of Wisconsin Genetics
Computer Group software (16). The complete nucleotide sequence of a
6034-bp genomic fragment and the p55Cdc cDNA sequence
has been deposited in GenBankTM (accession nos. AF322919
and AF312208).
RNA Isolation, Northern Blotting, and DNA Probes--
Total RNA
was isolated using the ULTRASPECTM RNA Isolation System
(Biotecx) from the different tissues of a 6-week-old NMRI male
mouse kept at room temperature and from the brown adipose tissue of
another sibling male mouse that was cold-exposed at 4 °C for 3 days.
Northern blotting and hybridization were performed as previously
described (5).
The DNA probes used were the Elovl1 ORF probe (a 923-bp
fragment corresponding to nt 104-1027 in the Elovl1
cDNA) and the p55Cdc probe (a 1.75-kb fragment
corresponding to full-length cDNA). The probes were labeled with
[
-32P]dCTP using a random-primed DNA labeling kit
(Roche Molecular Biochemicals).
RT-PCR Transcription Analysis--
DNase-treated total RNA (1.5 µg from brown fat, kidney, heart, and liver) was reverse-transcribed
and amplified in one step using a Promega Access RT-PCR System kit
(cat. no. A1250). The PCR reaction was carried out with the primers:
forward, 5'-CGGGAAACCACTGAGATTGT-3' and reverse,
5'-ATCTTCCTTATGTCCCAGCA-3', for the Elovl1 amplification; and the primers forward, 5'-CTCAGCGGCAAACCTCAGAA-3' and reverse, 5'-ACTGGTTCCTCCTCCTGTTG-3' for p55Cdc amplification. The
following cycle parameters were used: 48 °C for 45 min, 94 °C for
2 min (RT), 94 °C for 30 s, 60 °C for 1 min, 68 °C
for 2 min (40 cycles), 68 °C for 7 min (PCR), 4 °C soak. The PCR
products were electrophoresed in a 2% agarose gel in 0.5× Tris
borate/EDTA buffer and photographed.
PCR Analysis of the Elovl1/p55Cdc Gene Linkage--
For PCR
analysis of the Elovl1/p55Cdc gene linkage
genomic C57BL/6 mouse DNA was used as template. The PCR reaction was
carried out with primers 5'-GTCAGAATGGGCAGGCAGCA-3', complementary to mouse Elovl1 genomic sequence 5008-5027, and
5'-GGGGCCTGTCTGAGTGCTGTGGAT-3', complementary to p55Cdc
mouse mRNA sequence 1287-1310.
DNA Extraction and Southern Blotting--
Genomic DNA was
prepared from mouse tails by the simplified mammalian DNA isolation
procedure published by Laird et al. (17). Tail biopsies were
collected from 3-week-old mice of the C57BL/6J strain and used directly
for DNA isolation.
Digested DNA was separated on an 0.8% agarose gel and transferred to a
Hybond N+ membrane (Amersham Biosciences) according to standard
procedures (15). Hybridization and washing conditions were identical to
those used for library screening, except that the second wash was
carried out under low-stringency conditions (15 min at 40 °C in
0.5× SSC, 0.1% SDS). The radiolabel was detected by exposure to
DuPont Cronex x-ray films with an intensifying screen at
80 °C.
Cell Culture--
HIB-1B cells, provided by Dr. B. Spiegelman
(Boston, MA), were grown in pre-adipocyte medium (PAM), i.e.
Dulbecco's modified Eagle's medium, supplemented with 2 mM glutamine and 10% heat-inactivated fetal calf serum
(18). Cells were induced to differentiate in adipocyte medium (AM) by
the addition of 20 nM insulin and 1 nM triiodothyronine. At this stage, the cells were allowed to become confluent without a change of medium for up to 3 days (19).
 |
RESULTS |
Isolation of a Mouse Elovl1 Genomic Clone--
A 129 SvJ mouse
genomic DNA library was screened with an Elovl1 cDNA
probe (4) that resulted in a clone containing a 17-kb fragment. By
subsequent hybridization with probes specific for the 5'- and 3'-ends
of the Elovl1 cDNA, the fragment was identified as
covering the entire Elovl1 gene. The nucleotide sequence was determined by primer walking strategy directly from the phage DNA.
Organization of the Elovl1 Gene--
The Elovl1 gene
spans ~5.4 kb of genomic DNA and is composed of eight exons (Fig.
1A). The exons range in size
from 58 to 720 bp and the introns range from 77 to 2285 bp. The
sequences at the exon/intron junctions are reported in Table
I. As indicated, the splice junctions of
the seven intervening introns are well conserved and follow the gt-ag
rule (20) and score highly in terms of the derived consensus sequences
at these sites (21). In contrast to our sequencing data obtained from a
full-length Elovl1 cDNA (4), we were unable to identify
a genomic sequence containing the first 41 bp previously described
within the cDNA fragment. However, our genomic sequence does not
contain a conserved splice acceptor site, which would have supported
the existence of an extra 5'-exon. Furthermore, we have not been able
to retrieve any EST sequence containing the extra 41 bp. This
difference is presumably due to a cloning artifact of the mouse
cDNA because the human gene (GenBankTM accession no.
AL139289) also lacks the corresponding sequence. The translation
initiation codon (ATG) is located in the second exon, and the protein
coding sequence stretches into the eighth exon. The proximal promoter
sequence does not contain a TATA-box consensus site. Instead, there are
several short interspersed GC-rich elements in the close vicinity of
the transcription start site. The polyadenylation signal earlier
described by Tvrdik et al. (4) is located within the eighth
exon at 5064-5070 bp.

View larger version (13K):
[in this window]
[in a new window]
|
Fig. 1.
Schematic representation of the
Elovl1 and p55Cdc loci.
A, exon/intron structure and orientation of
Elovl1 and p55Cdc. Exons are numbered and
indicated by boxes on the transcribed DNA strand.
Protein-coding regions within the mouse genomic sequence are
solid, 5' and 3' untranslated regions are hatched
and correspond to the Elovl1 and p55Cdc mRNA
sequence (previously published by us (4) and in this paper,
respectively) (GenBankTM accession nos. AF170907 and
AF312208). Polyadenylation signal consensus sequences (pA)
are marked by small vertical arrows. Numbers
above the sketch refer to nucleotide positions in
GenBankTM accession no. AF322919 of the mouse genomic
sequence. One EST cDNA fragment (GenBankTM accession
no. AA718173/BM445297) corresponding to the 3'-end of mouse
Elovl1 mRNA is positioned according to its homology with
the genomic DNA. The hatched intron sequence and the
solid white exons within the p55Cdc gene
correspond to data obtained from the rat gene (14)
(GenBankTM accession no. AF052695). B, PCR
analysis of 3' Elovl1/p55Cdc genomic mouse DNA.
Genomic DNA (gDNA; 1.5 µg) was amplified with mouse
sequence-specific primers as described under "Materials and
Methods" and shown in A. M, 1-kb Plus DNA
Ladder molecular weight marker (Invitrogen).
|
|
View this table:
[in this window]
[in a new window]
|
Table I
Exon/intron boundary sequences of the mouse Elovl1 gene
Exon sequences are in capital letters. The nucleotide consensus
sequence of the intron splice junctions are shown in boldface. The
amino acid positions encoded by spliced codons are indicated in
parentheses.
|
|
Elovl1 Is a Single Copy Gene--
To verify if Elovl1
is a single copy gene we performed a Southern blot analysis of
mouse DNA. As shown in Fig. 2, following digestion with BglI, SacI, and XbaI,
the mouse Elovl1 ORF probe only strongly hybridized to
genomic fragments that were of the predicted size, suggesting that
Elovl1 is a single copy gene in the mouse genome.

View larger version (57K):
[in this window]
[in a new window]
|
Fig. 2.
Detection of the Elovl1 gene
in mouse genomic DNA. Southern blot analysis was performed with 10 µg/lane of mouse genomic DNA digested with the indicated restriction
enzymes: B, BglI; S, SacI;
X, XbaI. The blot was hybridized to the
Elovl1 ORF probe and washed as described under "Materials
and Methods."
|
|
Elovl1 Is Tightly Linked to p55Cdc--
Sequencing of the
untranscribed flanking regions of the Elovl1 gene revealed
that the cloned insert contained part of yet another gene closely
linked to the 3'-end of the Elovl1 gene. A BLAST search
identified the sequence as corresponding to the cell cycle gene
p55Cdc (Fig. 1A) (14). p55Cdc is a
mammalian homolog of a family of cell cycle proteins from widely
divergent species that has been implicated in cell cycle-regulated
ubiquitin-mediated proteolysis (22-25). The p55Cdc gene
consists of 10 exons and has been analyzed in detail in rat
(GenBankTM accession no. AF-052695) (14) (Fig.
1A) but not in mouse or man. Our lambda genomic clone covers
the last 688 nucleotides of the p55Cdc gene including the
last exon and intron and part of exon number 9. The sequence identity
between the published genomic rat p55Cdc and the sequence we
have determined from our genomic clone is 86% over a total region of
1189 nucleotides.
To confirm the Elovl1/p55Cdc organization in mouse we ran a
PCR with mouse genomic DNA as a template. An expected fragment of
~2200 bp was obtained with primers complementary to a sequence within
exon 8 of Elovl1 and within the mouse p55Cdc
mRNA corresponding to a sequence within exon 8 ~1900 bp into the
p55Cdc gene (see below and under "Materials and
Methods") (Fig. 1, A and B). Sequence analysis
of the DNA fragment confirmed the nucleotide identity as mouse
Elovl1/p55Cdc.
Although both Elovl1 and p55Cdc are highly
conserved genes, a BLAST search suggests that the tail-to-tail
arrangement has evolved in vertebrates (Table
II). Linkage data from the WICGR Mouse RH
Gene Map Release Data suggests that this region of human chromosome 1 has its equivalence on mouse chromosome 4.
View this table:
[in this window]
[in a new window]
|
Table II
Chromosomal arrangement of the Elovl1 and p55Cdc genes in different
organisms
The chromosomal arrangement of the Elovl1 and
p55Cdc genes is indicated as tail-to-tail or as separate
based on genomic sequences obtained by us (this paper) or through BLAST
search. The genomic sequences are indicated as accession numbers.
|
|
Identification of Full-length Mouse p55Cdc cDNA
Sequence--
The mRNA for p55Cdc has been sequenced
for rat and human (23) but not for mouse. To confirm the
p55Cdc sequence, we compared the genomic p55Cdc
sequence from mouse to the EST data base and found several highly
similar nucleotide sequences. Three clones (accession nos. AI327152,
AA497914, and AA537091) were acquired from the I.M.A.G.E. Consortium.
The full-length cDNA sequence was obtained by sequencing the
overlap of these three clones and a 735-bp RT-PCR product covering the
3'-end of p55Cdc mRNA. The nucleotide sequence is shown
in Fig. 3.

View larger version (46K):
[in this window]
[in a new window]
|
Fig. 3.
Nucleotide sequences of p55Cdc
cDNA. Indirect amino acid sequences of the corresponding
p55Cdc polypeptide were shown below the open reading frame.
Polyadenylation signal consensus sequence is underlined.
Sequence data have been deposited under the GenBankTM
accession no. AF312208.
|
|
Sequence identity between the cDNA sequence and the sequence we
determined from our genomic clone was 100% over a total region of 243 nucleotides. The sequence identity between the published rat cDNA
p55Cdc and the mouse cDNA was 91%.
Overlapping 3'-Ends of a Long Elovl1 and p55Cdc mRNA
Species--
Elovl1 and p55Cdc are oriented in a
tail-to-tail manner in a remarkably tight linkage. In fact, there
exists a submitted EST sequence from the WashU-HHMI Mouse EST Project
with accession number AA718173 corresponding to a Elovl1
mRNA from mammary gland that appears to overlap the transcribed
p55Cdc mRNA with 16 nucleotides. We acquired the clone
and verified the complete nucleotide sequence versus our
genomic clone over a total region of 560 nucleotides. From our sequence
data, we were able to identify 37 additional nucleotides, which were
complementary to exon 10 of the p55Cdc gene, as well as a
50-bp-long poly(A) tail (GenBankTM accession no. BM445297).
These results show that there is a total overlap of 53 nucleotides in
the two transcripts (Figs. 1A and
4C). Because we have
not detected more than one mRNA species on our Northern blots (see
Fig. 6), this is probably not a major cleavage site of
Elovl1 transcription.

View larger version (18K):
[in this window]
[in a new window]
|
Fig. 4.
Nucleotide sequence alignment of one
Elovl1 EST clone obtained from mammary gland with
genomic DNA (GenBankTM accession no. AF322919) and 3'-end
of p55Cdc cDNA. A, 3'-end cDNA
sequences corresponding to primary mRNA species cleaved immediately
downstream of the polyadenylation signal (AATTAAA) in
Elovl1 (AF170907). B, cDNA sequences
corresponding to overlapping transcripts and predicted polyadenylation
signal for the long Elovl1 transcript obtained from mammary
gland (GenBankTM accession no. BM445297). AF312208,
p55Cdc cDNA GenBankTM accession no.
|
|
To confirm the presence of overlapping mRNA species in different
tissues, we performed RT-PCR on total RNA from brown adipose tissue,
kidney, heart, and lung with primers corresponding to the
3'-untranslated region of the long Elovl1 mRNA from
mammary gland (GenBankTM accession no. AA718173). As shown
in Fig. 5A, we amplified the
anticipated 307 bp product (primers from nt 5075 to 5094 and nt 5363 to
5382 in the genomic clone) in brown adipose tissue, kidney, heart, and
lung, confirming that such Elovl1 transcripts exist that
overlap p55Cdc by 53 bp (Fig. 4C). In contrast,
we were unable to amplify a specific fragment within the same tissues with primers specific for p55Cdc (primers from nt 516 to 535 and nt 1234 to 1253 in the cDNA clone) (Fig. 5B).

View larger version (38K):
[in this window]
[in a new window]
|
Fig. 5.
PCR analysis of 3' Elovl1
mRNA (A) and p55Cdc
mRNA (B) expression in mouse tissues.
DNase-treated total RNA (1.5 µg) was reverse-transcribed and
amplified. Lane 1, brown fat; lane 2, kidney;
lane 3, heart; lane 4, liver; lane 5,
p55Cdc cDNA. M, 1-kb Plus DNA Ladder
molecular weight marker (Invitrogen).
|
|
Contrasting Expression of Elovl1 and p55Cdc in Different Mouse
Tissues--
The ELOVL1 protein is involved in the formation of
membrane lipids and earlier results revealed that Elovl1 was
ubiquitously expressed (4). The p55Cdc is highly expressed
in proliferating but not in differentiated or growth-arrested cells
(24).
To verify the Elovl1 and p55Cdc expression, we
first compared the mRNA levels within different tissues. As seen in
Fig. 6, the expression pattern in
different tissues was dissimilar for the two genes. In agreement with
our earlier results, the Elovl1 expression was diversified
in different mouse tissues, with the highest steady-state mRNA
levels in stomach, lung, kidney, skin, intestine, and some specific
brain tissues, whereas white fat, liver, spleen, brown fat, heart, and
muscle showed moderate Elovl1 expression. Only a very weak
Elovl1 mRNA signal was found in the testis.

View larger version (44K):
[in this window]
[in a new window]
|
Fig. 6.
Elovl1 and p55Cdc
mRNA levels in mouse tissues. Northern blot analyses
were performed with 10 µg of total RNA isolated from the tissues
indicated. BAT, 4 °C, refers to RNA isolated from the
brown adipose tissue of a mouse exposed to 4 °C for 3 days. All
other RNA samples were isolated from animals kept at thermoneutral
temperature (28 °C). WAT, white adipose tissue; SK.
MUSCLE, skeletal muscle. The membranes were probed with
32P-labeled cDNA fragments corresponding to open
reading frames of Elovl1 and p55Cdc, respectively
and subsequently exposed to DuPont Cronex x-ray films for up to 1 week.
The position of the ribosomal 18 S RNA is indicated on the
right.
|
|
In contrast, the highest level of p55Cdc mRNA was found
in testis, whereas spleen and intestine showed moderate expression. Low
or undetectable amounts of p55Cdc mRNA were obtained
from fat tissue, liver, brain, lung, stomach, muscle tissue, and skin.
Elovl1 and p55Cdc Expression Is Affected in a Similar Way During
Differentiation of HIB-1B Cells--
To see if the pattern of mRNA
levels for the two genes was synchronously affected during cell growth,
we analyzed the expression pattern in a brown fat cell line, HIB-1B,
during a proliferative stage and when cells were induced to
differentiate. These cells, which are derived from a brown fat
hibernoma, are known to differentiate in culture when they reach
confluence and are subsequently exposed to a differentiation medium
(18). During the preconfluent stage, the cells showed the highest level
of expression of both genes (Fig. 7).
After confluence, the cells showed decreased levels of both
Elovl1 and p55Cdc mRNA with time, even if the
culture medium was not changed to differentiation medium. This
indicates that, although the genes were shown to be independently
regulated in a tissue-specific manner, during a specific phase of
development, certain cells may have a synchronized expression of
Elovl1 and p55Cdc mRNA.

View larger version (66K):
[in this window]
[in a new window]
|
Fig. 7.
Elovl1 and p55Cdc
mRNA levels in cultured HIB-1B cells. Northern blot
analyses were performed with 10 µg of total RNA isolated from cells
cultured in pre-adipocyte medium (PAM) until confluence
(PAM, 0), after confluence for 2 days in
pre-adipocyte medium (PAM, 2), or for 2 or 3 days
in adipocyte medium (AM, 2 and
3).
|
|
 |
DISCUSSION |
Elovl1 is a highly conserved gene and a member of a
recently recognized mammalian gene family whose products have been
indicated as being involved in the formation of very long chain fatty
acids and sphingolipids (4)
We have isolated here a lambda phage genomic DNA clone containing the
entire mouse Elovl1 gene. Although the length of the gene,
as well as the transcript, is relatively similar to the closely related
gene Elovl3, the exon-intron structure is markedly different
(8 exons versus 4 exons) (6). Because the encoded polypeptides are very similar both in size and sequence, there is no
obvious explanation for these structural differences.
Surprisingly, sequencing of the lambda clone revealed that the insert
contained the 3' part of the newly identified cell cycle gene
p55Cdc (14) in the opposite orientation. The genes are very
tightly linked, so the 3'-ends of their long mRNA species are
complementary over a short stretch of nucleotides.
Despite the fact that overlapping genes are rare events in eukaryotes
(26-28), a similar tail-to-tail arrangement was also found for the
Elovl3 gene and the homeobox gene Pitx3 (6). Except for homologous genes that may have arisen by gene duplication, adjacent genes are normally separated by tens to hundreds of kilobases within the mammalian genome. It is therefore intriguing that two closely related genes from the same gene family are both juxtaposed with two completely unrelated genes within an 8-9-kb stretch in a
tail-to-tail arrangement.
The ELOVL1 protein has been identified as a fatty acid elongase, which
elongates VLCFAs up to 26 carbon atoms (4). Under normal circumstances,
a substantial amount of VLCFA is linked to a long chain sphingoid base
sphinganine, forming a ceramide, which constitutes the lipid backbone
of sphingomyelin and other sphingolipids. Sphingolipids are essential
for cell proliferation. Impaired sphingolipid synthesis leads to
cessation of cell growth both in yeast (29) and mammalian cells (30).
Concomitantly, p55Cdc is the mammalian homolog to the cell
cycle protein CDC20p in yeast (22, 23) and the Fizzy protein in
Drosophila (31) and is required for the metaphase-anaphase transition
(32). EST sequences corresponding to both mRNAs can be found as
early as in the fertilized egg during mouse development. It is
therefore probable that the two genes are expressed during the
proliferative phase in any cell type.
Obviously, overlapping genes in opposite orientation generate
transcripts that could form RNA duplexes if present in the same cell.
In particular, several recent reports show that short stretches of
double-stranded RNA molecules may serve as a template for specific RNA
nuclease activity leading to gene silencing (33-35). Because both
Elovl1 and p55Cdc genes exhibit a rather
ubiquitous tissue expression pattern at some point, we can therefore
not exclude this possibility that a short tail-to-tail sense-antisense
structure may serve as a template for specific RNA nuclease activity
leading to gene silencing.
Interestingly, there is an identical 9-bp element, CTCAAAAGA, within
the 3'-untranslated region of each gene, 124 and 126 bp, respectively,
downstream from the sites where the poly(A) tails are added onto each
of the genes. We searched the data base for factors that could
recognize this element but no such finding occurred.
The promoter of the p55Cdc gene has been analyzed in rat and
contains several cell cycle regulatory motifs, which are known to
repress constitutive transcription during G0 and early
G1 phases of the cell cycle (14). In our study, we show
that Elovl1 and p55Cdc have a distinct
tissue-specific expression. However, in synchronized brown fat cells,
we found that the expression of both genes was high during the
proliferative phase and decreased upon differentiation of the cells.
This is in agreement with p55Cdc being strictly expressed
during mitosis. Notably, although Elovl1 is ubiquitously
expressed, its expression is also decreased during differentiation of
the cells. This may indicate that both genes are under a common
regulator(s) during the cell cycle. One could speculate that there are
common constitutive factors that keep the Elovl1-p55Cdc
locus in a transcriptionally open position but only during a
proliferative phase, and in addition to this there are specific cell
cycle factors that apply a specific restriction on the
p55Cdc gene. However, an understanding of the mechanism of
action of this interesting gene interaction must await further knowledge about interacting factors within the Elovl1 gene.
 |
ACKNOWLEDGEMENTS |
We thank Birgitta Leksell for technical
assistance and Jan Nedergaard for valuable comments and suggestions
during manuscript preparation.
 |
FOOTNOTES |
*
This work was supported by grants from the Swedish Natural
Science Research Council.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
The nucleotide sequence(s) reported in this paper has been submitted to the GenBankTM/EBI Data Bank with accession number(s) AF322919, AF312208, and BM445297.
To whom correspondence should be addressed: The Wenner-Gren
Institute, The Arrhenius Laboratories F3, Stockholm University, SE-10691 Stockholm, Sweden. Tel.: 46-8-164127; Fax: 46-8-156756; E-mail: anders.jacobsson@wgi.su.se.
Published, JBC Papers in Press, March 12, 2002, DOI 10.1074/jbc.M111503200
2
In accordance with the Mouse and Human
Nomenclature Committees the assigning symbols for the mouse genes
Scc1, Ssc2, and Cig30 are changed to
Elovl1, Elovl2, and Elovl3, respectively.
 |
ABBREVIATIONS |
The abbreviations used are:
VLCFA, very long
chain fatty acids;
EST, expressed sequence tag;
RT, reverse
transcription;
ORF, open reading frame;
PAM, pre-adipocyte medium;
nt, nucleotides..
 |
REFERENCES |
| 1.
|
Poulos, A.,
Gibson, R.,
Sharp, P.,
Beckman, K.,
and Grattan-Smith, P.
(1994)
Ann. Neurol.
36,
741-746[CrossRef][Medline]
[Order article via Infotrieve]
|
| 2.
|
Stewart, M. E.,
and Downing, D. T.
(1999)
J. Lipid Res.
40,
1434-1439[Abstract/Free Full Text]
|
| 3.
|
Cinti, D. L.,
Cook, L.,
Nagi, M. N.,
and Suneja, S. K.
(1992)
Prog. Lipid Res.
31,
1-51[CrossRef][Medline]
[Order article via Infotrieve]
|
| 4.
|
Tvrdik, P.,
Westerberg, R.,
Silve, S.,
Asadi, A.,
Jakobsson, A.,
Cannon, B.,
Loison, G.,
and Jacobsson, A.
(2000)
J. Cell Biol.
149,
707-717[Abstract/Free Full Text]
|
| 5.
|
Tvrdik, P.,
Asadi, A.,
Kozak, L. P.,
Nedergaard, J.,
Cannon, B.,
and Jacobsson, A.
(1997)
J. Biol. Chem.
272,
31738-31746[Abstract/Free Full Text]
|
| 6.
|
Tvrdik, P.,
Asadi, A.,
Kozak, L. P.,
Nuglozeh, E.,
Parente, F.,
Nedergaard, J.,
and Jacobsson, A.
(1999)
J. Biol. Chem.
274,
26387-26392[Abstract/Free Full Text]
|
| 7.
|
Revardel, E.,
Bonneau, M.,
Durrens, P.,
and Aigle, M.
(1995)
Biochim. Biophys. Acta
1263,
261-265[Medline]
[Order article via Infotrieve]
|
| 8.
|
Millar, A. A.,
and Kunst, L.
(1997)
Plant J.
12,
121-131[CrossRef][Medline]
[Order article via Infotrieve]
|
| 9.
|
Oh, C. S.,
Toke, D. A.,
Mandala, S.,
and Martin, C. E.
(1997)
J. Biol. Chem.
272,
17376-17384[Abstract/Free Full Text]
|
| 10.
|
Millar, A. A.,
Clemens, S.,
Zachgo, S.,
Giblin, E. M.,
Taylor, D. C.,
and Kunst, L.
(1999)
Plant Cell
11,
825-838[Abstract/Free Full Text]
|
| 11.
|
Beaudoin, F.,
Michaelson, L. V.,
Hey, S. J.,
Lewis, M. J.,
Shewry, P. R.,
Sayanova, O.,
and Napier, J. A.
(2000)
Proc. Natl. Acad. Sci. U. S. A.
10,
6421-6426
|
| 12.
|
Leonard, A. E.,
Bobik, E. G.,
Dorado, J.,
Kroeger, P. E.,
Chuang, L.-T.,
Thurmond, J. M.,
Parker-Barnes, J. M.,
Das, T.,
Huang, Y.-S.,
and Mukerji, P.
(2000)
Biochem. J.
350,
765-770[CrossRef][Medline]
[Order article via Infotrieve]
|
| 13.
|
Zhang, K.,
Kniazeva, M.,
Han, M., Li, W., Yu, Z.,
Yang, Z., Li, Y.,
Metzker, M. L.,
Allikmets, R.,
Zack, D. J.,
Kakuk, L. E.,
Lagali, P. S.,
Wong, P. W.,
MacDonald, I. M.,
Sieving, P. A.,
Figueroa, D. J.,
Austin, C. P.,
Gould, R. J.,
Ayyagari, R.,
and Petrukhin, K.
(2001)
Nat. Genet.
27,
89-93[Medline]
[Order article via Infotrieve]
|
| 14.
|
Weinstein, J.,
Karim, J.,
Geschwind, D. H.,
Nelson, S. F.,
Krumm, J.,
and Sakamoto, K. M.
(1998)
Mol. Genet. Metab.
64,
52-57[CrossRef][Medline]
[Order article via Infotrieve]
|
| 15.
|
Sambrook, J.,
Fritsch, E. F.,
and Maniatis, T.
(1989)
Molecular Cloning, A Laboratory Manual, second edition
, Cold Spring Harbor Laboratory Press, New York
|
| 16.
|
Devereux, J.,
Haeberli, P.,
and Smithies, O.
(1984)
Nucleic Acids Res.
12,
387-395[Abstract/Free Full Text]
|
| 17.
|
Laird, P. W.,
Zijderveld, A.,
Linders, K.,
Rudnicki, M. A.,
Jaenisch, R.,
and Berns, A.
(1991)
Nucleic Acids Res.
19,
4293-4293[Free Full Text]
|
| 18.
|
Ross, S. R.,
Choy, L.,
Graves, R. A.,
Fox, N.,
Solevjeva, V.,
Klaus, S.,
Ricquier, D.,
and Spiegelman, B. M.
(1992)
Proc. Natl. Acad. Sci. U. S. A.
89,
7561-7565[Abstract/Free Full Text]
|
| 19.
|
Antonson, P.,
Pray, M. G.,
Jacobsson, A.,
and Xanthopoulos, K. G.
(1995)
Eur. J. Biochem.
232,
397-403[Medline]
[Order article via Infotrieve]
|
| 20.
|
Breathnach, R.,
and Chambon, P.
(1981)
Annu. Rev. Biochem.
50,
349-383[CrossRef][Medline]
[Order article via Infotrieve]
|
| 21.
|
Shapiro, M. B.,
and Senapathy, P.
(1987)
Nucleic Acids Res.
15,
7155-7174[Abstract/Free Full Text]
|
| 22.
|
Sehti, N.,
Monteagudo, M. C.,
Koshland, D.,
Hogan, E.,
and Burke, D. J.
(1991)
Mol. Cell. Biol.
11,
5592-5602[Abstract/Free Full Text]
|
| 23.
|
Weinstein, J.,
Jacobsen, F. W.,
Hsu-Chen, J., Wu, T.,
and Baum, L. G.
(1994)
Mol. Cell. Biol.
14,
3350-3363[Abstract/Free Full Text]
|
| 24.
|
Weinstein, J.
(1997)
J. Biol. Chem.
272,
28501-28511[Abstract/Free Full Text]
|
| 25.
|
Fang, G., Yu, H.,
and Kirschner, M. W.
(1998)
Genes Dev.
12,
1871-1883[Abstract/Free Full Text]
|
| 26.
|
Lerner, A.,
D'Adamio, L.,
Diener, A. C.,
Clayton, L. K.,
and Reinherz, E. L.
(1993)
J. Immunol.
151,
3152-3162[Abstract]
|
| 27.
|
Batshake, B.,
and Sundelin, J.
(1996)
Biochem. Biophys. Res. Commun.
227,
70-76[CrossRef][Medline]
[Order article via Infotrieve]
|
| 28.
|
Campbell, H. D.,
Fountain, S.,
Young, I. G.,
Claudianos, C.,
Hoheisel, J. D.,
Chen, K. S.,
and Lupski, J. R.
(1997)
Genomics
42,
46-54[CrossRef][Medline]
[Order article via Infotrieve]
|
| 29.
|
Wells, G. B.,
and Lester, R. L.
(1983)
J. Biol. Chem.
258,
10200-10203[Abstract/Free Full Text]
|
| 30.
|
Hanada, K.,
Nishijima, M.,
Kiso, M.,
Hasegawa, A.,
Fujita, S.,
Ogawa, T.,
and Akamatsu, Y.
(1992)
J. Biol. Chem.
267,
23527-23533[Abstract/Free Full Text]
|
| 31.
|
Dawson, I. A.,
Roth, S.,
and Artavanis-Tsakonas, S.
(1995)
J. Cell Biol.
129,
725-737[Abstract/Free Full Text]
|
| 32.
|
Kramer, E. R.,
Gieffers, C.,
Holzl, G.,
Hengstschlager, M.,
and Peters, J. M.
(1998)
Curr. Biol.
8,
1207-1210[CrossRef][Medline]
[Order article via Infotrieve]
|
| 33.
|
Fire, A., Xu, S.,
Montgomery, M. K.,
Kostas, S. A.,
Driver, S. E.,
and Mello, C. C.
(1998)
Nature
391,
806-811[CrossRef][Medline]
[Order article via Infotrieve]
|
| 34.
|
Bass, B. L.
(2000)
Cell
101,
235-238[CrossRef][Medline]
[Order article via Infotrieve]
|
| 35.
|
Domeier, M. E.,
Morse, D. P.,
Knight, S. W.,
Portereiko, M.,
Bass, B. L.,
and Mango, S. E.
(2000)
Science
289,
1928-1930[Abstract/Free Full Text]
|
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
Y. Wang, D. Botolin, B. Christian, J. Busik, J. Xu, and D. B. Jump
Tissue-specific, nutritional, and developmental regulation of rat fatty acid elongases
J. Lipid Res.,
April 1, 2005;
46(4):
706 - 715.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. L. Hargrove, P. Greenspan, and D. K. Hartle
Nutritional Significance and Metabolism of Very Long Chain Fatty Alcohols and Acids from Dietary Waxes
Experimental Biology and Medicine,
March 1, 2004;
229(3):
215 - 226.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.